Dr. WAEL KHREISAT | Pediatric Neurology | Best Research Article Award

Dr. WAEL KHREISAT | Pediatric Neurology – Head of the pediatric department of royal medical service, Jordan

Dr. Wael Hayel Khreisat is a prominent figure in pediatric neurology with over 30 years of experience dedicated to advancing child healthcare and neurological research. Currently serving as a senior consultant and department head within Jordan’s leading medical institutions, his work reflects a harmonious blend of clinical excellence, academic commitment, and humanitarian service. From his foundational training in pediatrics to his specialization in pediatric neurology, Dr. Khreisat’s medical journey showcases a consistent passion for improving outcomes in pediatric neurodevelopment and epileptic disorders. His expertise is widely recognized not only in clinical settings but also in research and education, where he contributes to the academic development of future medical professionals.

Profile:

Orcid | Scopus

Education:

Dr. Khreisat began his medical education by earning his M.B.B.S. degree in 1991. He later obtained the Jordanian Board in Pediatrics in 1999 and further specialized in Pediatric Neurology, receiving board certification in 2019. His clinical training was enriched by postdoctoral fellowships at the Children’s Hospital of Pittsburgh and Rochester Hospital, New York, where he received hands-on experience in advanced pediatric neurological diagnostics and therapeutics. These academic milestones laid the groundwork for his continued clinical innovation and leadership in pediatric neurophysiology.

Professional Experience:

Dr. Khreisat’s career spans leadership roles such as Consultant Pediatric Neurologist at King Hussein Medical Center and Chair of the Pediatric Neurology Department at Queen Rania Hospital. He has also held academic appointments as an OSCE examiner and clinical educator at several Jordanian medical universities. With over two decades in service, he has practiced in critical care, neonatal intensive units, and neurodiagnostics, and led efforts in humanitarian missions across the Middle East and Africa. His work in EEG, EMG, and nerve conduction studies is foundational to his clinical reputation, with a diagnostic acumen that has helped countless children with complex neurological conditions.

Research Interest:

Dr. Khreisat’s research interests revolve around pediatric epilepsy, pharmacogenetics, neurodevelopmental disorders, and neuropharmacology. He is especially focused on the impact of gene polymorphisms on the responsiveness to antiepileptic drugs in children, advocating for more personalized and genetically informed treatment approaches. His involvement in multidisciplinary studies has contributed significantly to the understanding of autism spectrum disorders, juvenile epilepsy, and neurological side effects of pediatric medications.

Awards & Recognition:

Dr. Khreisat’s career reflects numerous acknowledgments from his peers and medical boards. Though specific personal awards are not listed, his nomination for the “Best Research Article Award” is driven by the impact and clinical significance of his work, particularly in pharmacogenomics and pediatric neurology. His leadership roles in medical boards and scientific committees further underscore the professional trust placed in his knowledge and expertise.

Publications:

Dr. Khreisat has authored and co-authored numerous impactful articles, with the following being particularly notable for this nomination:

📘 1. Atomoxetine Treatment of ADHD in Autism Spectrum Disorder (2024, Children – Basel) – Offers insights on ADHD treatment in young autistic children. Cited by: 12 articles.

📙 2. Genetic Polymorphisms and Epilepsy Susceptibility (2019, Pharmgenomics Pers Med) – A pivotal study linking CYP3A5 and CHRM2 to drug response. Cited by: 40+.

📗 3. Role of Clinical Pharmacist in Pediatric Epilepsy Adherence (2022, J Pharm Technol) – Highlights interdisciplinary healthcare. Cited by: 18 articles.

📕 4. Potassium Channel Gene and Drug Response (2018, J Pers Med) – Explores ion-channel genetics in epilepsy. Cited by: 22+.

📘 5. Effects of MTHFR and ABCC2 Gene Polymorphisms (2019, Pharmgenomics Pers Med) – Examines metabolic pathways in AED response. Cited by: 30+.

📙 6. Clinical Profile of Infants with Hypsarrhythmia (2011, Acta Inform Med) – Focused on infantile spasms. Cited by: 10+.

📗 7. Risk Factors of Birth Asphyxia (2005, Pak J Med Sci) – Important epidemiological contribution. Cited by: 16.

Conclusion:

Dr. Khreisat exemplifies the rare combination of a practicing clinician, dedicated educator, and impactful researcher. His expertise in pediatric neurology is matched by his scholarly contributions, particularly in areas of pharmacogenetics and epilepsy. As an advocate of evidence-based, patient-centered care, he continues to inspire the medical community through innovative research, academic mentorship, and service. His nomination for the “Best Research Article Award” is a testament to the relevance, quality, and global significance of his contributions to the field.

Dr. Wael Khreisat | Pediatric Neurology | Best Researcher Award

Dr. Wael Khreisat | Pediatric Neurology – Royal Medical Services, Jordan

Dr. Wael Hayel Khreisat is a distinguished pediatric neurologist and educator with over three decades of experience in pediatrics and neurology. Currently serving as the Head of the Pediatric Department at the Royal Medical Services in Jordan, he has made significant contributions to pediatric neurology through clinical excellence, research, and teaching. His expertise spans pediatric epilepsy, neuromuscular disorders, CNS infections, and EEG diagnostics. A passionate educator and examiner, Dr. Khreisat is deeply committed to advancing pediatric neurology in Jordan and beyond.

Profile Verification

ORCID | SCOPUS

Education

Dr. Khreisat earned his M.B.B.S. in 1991 from the School of Medicine at the University of Salah Al-Deen, Iraq. He completed his residency in pediatrics at King Hussein Medical Center, Amman, Jordan, in 1997. In 1999, he obtained the Jordanian Board of Pediatrics and, later in 2018, the Jordanian Board of Pediatric Neurology. His postdoctoral training includes prestigious programs at Rochester Hospital, New York, and Pittsburgh Children’s Hospital, Pennsylvania, focusing on pediatric neurology.

Experience

Dr. Khreisat has held various esteemed roles in his career, including Chair of Pediatric Neurology and Neurophysiology at Queen Rania Hospital for Children. He has been a consultant pediatric neurologist at King Hussein Medical Center since 2011 and has led numerous departments and committees. His international experience includes serving as a visiting pediatric neurologist in the U.S. and working in humanitarian missions with the United Nations. Dr. Khreisat’s dedication to education is evident through his roles as a teacher and examiner at multiple universities in Jordan, where he has shaped the future of medical professionals.

Research Interests

Dr. Khreisat’s research focuses on pediatric epilepsy, pharmacogenomics, and the genetic factors influencing neurological disorders. He is particularly interested in the responsiveness of antiepileptic drugs in pediatric populations and the role of genetic polymorphisms in epilepsy susceptibility. His work also explores innovative treatments for ADHD symptoms in children with autism spectrum disorder.

Awards

Dr. Khreisat’s exceptional service has been recognized through numerous awards and accolades. His contributions to pediatric neurology and education have made him a respected figure in Jordan and internationally. He continues to lead advancements in pediatric healthcare with dedication and excellence.

Publications

📚 “Atomoxetine Treatment of ADHD in Autism Spectrum Disorder” (2024) – Published in Children (Basel), this study explores the efficacy of Atomoxetine in young children with autism.

📚 “Genetic Polymorphisms and Epilepsy Susceptibility” (2019) – Published in Pharmgenomics Pers Med, this research examines the role of CYP3A5 and CHRM2 genes in epilepsy.

📚 “Pediatric Adherence to Antiepileptic Drugs” (2022) – Published in J Pharm Technol, this paper highlights the clinical pharmacist’s role in improving adherence.

📚 “Potassium Channel Gene Polymorphisms and Epilepsy” (2018) – Published in J Pers Med, this study investigates genetic influences on antiepileptic drug responsiveness.

📚 “Factors Affecting Antiepileptic Treatment in Pediatrics” (2020) – A study exploring the predictors of drug efficacy in Jordanian children.

📚 “Gene Polymorphisms and Antiepileptic Drug Responsiveness” (2019) – Published in Pharmgenomics Pers Med, focusing on MTHFR and ABCC2 genes.

📚 “Clinical Profile of Infants with Hypsarrhythmia” (2011) – Published in Acta Inform Med, this study examines infants with severe epileptic syndromes.

Conclusion

Dr. Wael Hayel Khreisat exemplifies excellence in pediatric neurology, combining clinical practice, research, and education. His leadership in advancing pediatric healthcare and his dedication to research make him a deserving candidate for any recognition of his outstanding contributions to medicine. Dr. Khreisat continues to inspire and mentor the next generation of medical professionals while providing exceptional care to his patients.